Xenon Pharmaceuticals Inc. (XENE) is listed on NASDAQ in Pharmaceutical Stocks. It is $59.99, -3.13%, with a $5.8B market cap. RSI is 39.6, near oversold. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 39.6 Near Oversold
Market Cap $5.8B
Volume 375.7K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-213.0M
EPS $-2.28
P/E Ratio -26.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Gannon Steven | Insider | Sell | 10,000 | $64.06 | $640,550 | 2026 Aug 11 |
| Patou Gary | Insider | Sell | 1,322 | $53.14 | $70,251 | 2026 Jun 5 |
| Cannon Gillian | Insider | Sell | 1,190 | $53.14 | $63,237 | 2026 Jun 5 |
| Kenney Christopher John | Chief Medical Officer | Sell | 1,410 | $55.23 | $77,867 | 2026 Mar 13 |
| Difabio Andrea | Chief Legal Officer | Sell | 1,342 | $55.22 | $74,112 | 2026 Mar 13 |
| Mortimer Ian | PRESIDENT & CEO | Sell | 7,308 | $55.23 | $403,584 | 2026 Mar 13 |
| Kenney Christopher John | Chief Medical Officer | Sell | 2,771 | $60.11 | $166,559 | 2026 Mar 10 |
| Difabio Andrea | Chief Legal Officer | Sell | 2,607 | $60.11 | $156,702 | 2026 Mar 10 |
| Mortimer Ian | PRESIDENT & CEO | Sell | 281,269 | $60.32 | $17.0M | 2026 Mar 10 |
| Mortimer Ian | PRESIDENT & CEO | Sell | 25,205 | $45.33 | $1.1M | 2025 Dec 8 |
| Mortimer Ian | PRESIDENT & CEO | Sell | 97 | $45.01 | $4,366 | 2025 Nov 28 |
| Mortimer Ian | PRESIDENT, CEO & INTERIM CFO | Sell | 25,000 | $40.16 | $1.0M | 2025 Oct 1 |
| Gannon Steven | Director | Sell | 3 | $30.48 | $91 | 2025 Jun 5 |
| Mortimer Ian | PRESIDENT & CEO | Sell | 55,000 | $40.25 | $2.2M | 2025 Jan 27 |
| Aulin Sherry | Chief Financial Officer | Sell | 18,709 | $41.21 | $770,912 | 2024 Dec 18 |
| Patou Gary | Director | Sell | 4,891 | $41.08 | $200,947 | 2024 Nov 22 |
| Garofalo Elizabeth A. | Director | Sell | 2,092 | $45.69 | $95,583 | 2024 Mar 8 |
| Gannon Steven | Director | Sell | 13,000 | $46.28 | $601,600 | 2024 Mar 7 |
| Robin Sherrington | EVP, Strategy & Innovation | Sell | 7,137 | $46.28 | $330,290 | 2024 Mar 7 |
| Patou Gary | Director | Sell | 18,978 | $39.99 | $758,983 | 2023 Dec 13 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $67.67 | 38.4 | $6.1B |
| | $48.69 | 60.7 | $3.1B |
Take XENE further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put XENE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Xenon Pharmaceuticals Inc. next reports.
Set alerts on XENE
Get notified when Xenon Pharmaceuticals Inc. hits your price targets or technical conditions are met.
Get Started Free